Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Keigo, Fujishita"'
Autor:
Keigo, Fujishita, Sando, Yasuhisa, Satoshi, Oka, Yuka, Fujisawa, Takuya, Machida, Toshi, Imai
Publikováno v:
Acta Medica Okayama. 76(1):17-24
R-CHOP therapy is generally performed every 3 weeks. We investigated the effects of extending the interval of R-CHOP therapy for > 1 week on the prognoses of patients with non-indolent non-Hodgkin’s B-cell lymphoma. Among the 338 patients with non-
Autor:
Kenta, Hayashino, Masayuki, Matsuda, Keigo, Fujishita, Jun, Iwata, Miki, Mizobuchi, Munenori, Uemura, Kenji, Yorita, Akiko, Maeshima, Toshi, Imai
Publikováno v:
Journal of Clinical and Experimental Hematopathology. 62:222-225
In the 2016 update of the World Health Organization (WHO) classification of myeloid neoplasms, acute undifferentiated leukemia (AUL) was defined by a lack of lineage-specific markers. AUL has very poor prognosis and no established therapies due to it
Publikováno v:
International journal of hematology. 116(4)
Autor:
Wataru, Kitamura, Takuya, Machida, Keigo, Fujishita, Satoshi, Oka, Yuka, Fujisawa, Katsuma, Tani, Toshi, Imai
Publikováno v:
[Rinsho ketsueki] The Japanese journal of clinical hematology. 61(4)
We present the case of a 39-year-old man with a primary diagnosis of mixed phenotype acute leukemia, T/myeloid not otherwise specified (T/M-MPAL). After achieving a complete remission (CR), he underwent allogeneic hematopoietic stem cell transplantat